Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors
Retrieved on:
Thursday, August 6, 2020
REDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker, Ph.D. to its board of directors, expanding membership to nine directors.
Key Points:
- REDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker, Ph.D. to its board of directors, expanding membership to nine directors.
- Dr. Aaker is the General Atlantic Professor at the Stanford Graduate School of Business, and a leading behavioral scientist, scholar, and best-selling author.
- Recognizing the ambitious growth strategy for Codexis and the importance of reshaping and aligning our organization and our corporate identity for that purpose, this as an ideal time to welcome Dr. Jennifer Aaker to the board.
- I look forward to combining the power of technology with human-centered design to help to create a strong future for Codexis.